All Signals
Company Overview
About
UltraSight is a medtech company that develops an AI-powered echocardiography platform enabling appropriately trained medical staff to perform cardiac ultrasound examinations.
Founders / Leaders
Davidi VortmanItay KezurerAchi LudomirskyYaron Lipman
Industry
MedTech
Location
Rehovot, Israel
Hiring
Active
Open Roles
Latest Funding Signal
$24M
Series BSeptember 23, 2026
UltraSight Raises $24M Series B to Expand AI Echocardiography Across U.S. Healthcare Systems
Lead Investors
Alive HealthTech Growth Fund
Other Investors
Deep Insight, Star51 Capital, Connecticut Innovations, eHealth Ventures, Mayo Clinic Ventures, NYU, Iron Nation
Use of Funds
UltraSight plans to use the funding to expand its commercial operations and implementation within U.S. healthcare systems and continue developing clinical applications for intensive care units.